BECU AI Inc. (KOSDAQ:148780)
South Korea · Delayed Price · Currency is KRW 2,225.00
-65.00 (-2.84%)
At close: Aug 5, 2025, 3:30 PM KST
Ligand Pharmaceuticals Revenue
BECU AI had revenue of 3.70B KRW in the quarter ending March 31, 2025, a decrease of -9.50%. This brings the company's revenue in the last twelve months to 16.91B, down -3.33% year-over-year. In the year 2024, BECU AI had annual revenue of 17.30B with 2.42% growth.
Revenue (ttm)
16.91B
Revenue Growth
-3.33%
P/S Ratio
3.94
Revenue / Employee
241.60M
Employees
70
Market Cap
66.66B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 17.30B | 408.06M | 2.42% |
| Dec 31, 2023 | 16.89B | 633.65M | 3.90% |
| Dec 31, 2022 | 16.26B | -759.59M | -4.46% |
| Dec 31, 2021 | 17.02B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition